Form 8-K - Current report:
SEC Accession No. 0001193125-22-071338
Filing Date
2022-03-10
Accepted
2022-03-10 08:15:14
Documents
14
Period of Report
2022-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d315187d8k.htm   iXBRL 8-K 25679
2 EX-99.1 d315187dex991.htm EX-99.1 46997
6 GRAPHIC g315187dsp0005.jpg GRAPHIC 3053
  Complete submission text file 0001193125-22-071338.txt   211804

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA snse-20220310.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE snse-20220310_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snse-20220310_pre.xml EX-101.PRE 11704
8 EXTRACTED XBRL INSTANCE DOCUMENT d315187d8k_htm.xml XML 3437
Mailing Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39980 | Film No.: 22727499
SIC: 2834 Pharmaceutical Preparations